Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biotechnology Index NYSE ETF (FBT)

Biotechnology Index NYSE ETF (FBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family First Trust Portfolios
  • Assets Under Management 1,969,452,000
  • Shares Outstanding, K 11,350
  • 60-Month Beta 0.99
Trade FBT with:
  • Price/Earnings ttm 25.78
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.020 on 09/23/15
  • Management Fee 0.55%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 18.76%
  • Historical Volatility 16.56%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 36.33% on 10/28/20
  • IV Low 18.76% on 06/23/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 13
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 244
  • Open Int (30-Day) 224

Price Performance

See More
Period Period Low Period High Performance
1-Month
160.15 +7.93%
on 06/03/21
176.64 -2.15%
on 06/10/21
+9.22 (+5.64%)
since 05/21/21
3-Month
154.84 +11.62%
on 03/25/21
176.64 -2.15%
on 06/10/21
+13.31 (+8.34%)
since 03/23/21
52-Week
149.50 +15.61%
on 09/11/20
186.51 -7.33%
on 02/10/21
+1.04 (+0.61%)
since 06/23/20

Most Recent Stories

More News
Biogen's Alzheimer's Drug Approval Puts Biotech ETFs in Spotlight

The FDA's approval of the first new drug to treat Alzheimer's disease in about 20 years has attracted investors' attention toward the biotech sector while sparking new controversies.

BIIB : 371.90 (-0.67%)
IBB : 160.50 (-0.25%)
XBI : 134.31 (+0.47%)
BBH : 197.93 (-0.12%)
FBT : 172.84 (-0.36%)
BTEC : 60.05 (+1.25%)
Top-Performing Biotech ETFs of Last Week

Investors may want to tap the bullishness in the sector with the best biotech ETFs of last week.

BIIB : 371.90 (-0.67%)
FBT : 172.84 (-0.36%)
SBIO : 48.82 (+0.25%)
BTEC : 60.05 (+1.25%)
ARKG : 88.52 (+0.96%)
GNOM : 23.29 (+1.39%)
ORPH : 7.44 (+24.62%)
CLOV : 13.83 (+9.50%)
Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.

SNY : 52.08 (-0.42%)
AZN : 57.98 (+0.16%)
PFE : 39.05 (-1.41%)
MRNA : 212.04 (-4.21%)
IBB : 160.50 (-0.25%)
XBI : 134.31 (+0.47%)
BBH : 197.93 (-0.12%)
FBT : 172.84 (-0.36%)
BTEC : 60.05 (+1.25%)
BNTX : 229.50 (-2.96%)
CVAC : 56.91 (-2.05%)
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines

The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.

JNJ : 162.63 (-0.61%)
AZN : 57.98 (+0.16%)
PFE : 39.05 (-1.41%)
MRNA : 212.04 (-4.21%)
IBB : 160.50 (-0.25%)
XBI : 134.31 (+0.47%)
BBH : 197.93 (-0.12%)
FBT : 172.84 (-0.36%)
BTEC : 60.05 (+1.25%)
Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.

JNJ : 162.63 (-0.61%)
AZN : 57.98 (+0.16%)
NVAX : 192.24 (-1.10%)
IBB : 160.50 (-0.25%)
XBI : 134.31 (+0.47%)
BBH : 197.93 (-0.12%)
FBT : 172.84 (-0.36%)
BTEC : 60.05 (+1.25%)
OCGN : 7.56 (+2.02%)
IBRX : 14.03 (+2.71%)
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

AZN : 57.98 (+0.16%)
PFE : 39.05 (-1.41%)
MRNA : 212.04 (-4.21%)
NVAX : 192.24 (-1.10%)
IBB : 160.50 (-0.25%)
XBI : 134.31 (+0.47%)
BBH : 197.93 (-0.12%)
FBT : 172.84 (-0.36%)
BTEC : 60.05 (+1.25%)
BNTX : 229.50 (-2.96%)
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 39.05 (-1.41%)
MRNA : 212.04 (-4.21%)
LLY : 217.10 (-1.96%)
IBB : 160.50 (-0.25%)
CNCR : 31.06 (+1.08%)
XBI : 134.31 (+0.47%)
BBH : 197.93 (-0.12%)
FBT : 172.84 (-0.36%)
SBIO : 48.82 (+0.25%)
PBE : 77.59 (+0.45%)
BTEC : 60.05 (+1.25%)
ARKG : 88.52 (+0.96%)
BNTX : 229.50 (-2.96%)
ETF Market Outlook & Picks for 2021

Two ETF experts share their market outlook and top picks for 2021.

XLI : 101.36 (-0.23%)
ICLN : 22.83 (-0.17%)
FBT : 172.84 (-0.36%)
EES : 49.37 (+0.11%)
KBWB : 63.43 (+0.57%)
RYH : 290.66 (-0.37%)
ARKG : 88.52 (+0.96%)
ONLN : 80.47 (+0.98%)
QQQM : 142.84 (unch)
EDOC : 19.15 (+1.06%)
ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

ALXN : 179.83 (+0.11%)
AZN : 57.98 (+0.16%)
PPH : 72.46 (-0.58%)
BBH : 197.93 (-0.12%)
FBT : 172.84 (-0.36%)
PJP : 79.53 (-0.68%)
PBE : 77.59 (+0.45%)
ETF Sectors to Bet on Positive Vaccine News

The introduction of the coronavirus vaccine is expected to help in the economic recovery, especially for sectors which have taken a hit from the social-distancing and lockdown measures.

XLE : 54.58 (+0.28%)
IBB : 160.50 (-0.25%)
CARZ : 61.40 (+0.79%)
XES : 64.84 (-0.12%)
XBI : 134.31 (+0.47%)
FBT : 172.84 (-0.36%)
JETS : 25.35 (-0.16%)
PEJ : 52.10 (+0.33%)
KBWB : 63.43 (+0.57%)
KRE : 65.85 (-0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted...

See More

Key Turning Points

3rd Resistance Point 175.71
2nd Resistance Point 174.69
1st Resistance Point 173.76
Last Price 172.84
1st Support Level 171.81
2nd Support Level 170.79
3rd Support Level 169.86

See More

52-Week High 186.51
Last Price 172.84
Fibonacci 61.8% 172.37
Fibonacci 50% 168.01
Fibonacci 38.2% 163.64
52-Week Low 149.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar